A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403
Oda, Naohiro, Hotta, Kastuyuki, Ninomiya, Kiichiro, Minami, Daisuke, Ichihara, Eiki, Murakami, Toshi, Yokoyama, Toshihide, Ichikawa, Hirohisa, Chikamori, Kenichi, Takigawa, Nagio, Ochi, Nobuaki, HaritLanguage:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-018-3694-5
Date:
October, 2018
File:
PDF, 838 KB
english, 2018